JAMA Network Home
Sign In
Viewpoint

The Clinical Indications for Mifepristone Go Beyond Abortion

JAMA 10.1001/jama.2025.13376

August 28, 2025 at 11:00 AM EDT

Read the full article

This Viewpoint discusses the broader medical value of mifepristone beyond abortion and the threat to patient safety for a variety of obstetric and gynecologic procedures that may be introduced by banning the medication.

Corresponding Author: Jessica Chen, MD, University of Pennsylvania, 3737 Market St, Philadelphia, PA 19104 (Jessica.chen1@pennmedicine.upenn.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.13376?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=082825

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks